| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |